LC/MS-Based Quantitative Proteomic Analysis of Paraffin-Embedded Archival Melanomas Reveals Potential Proteomic Biomarkers Associated with Metastasis

• Sharon K. Huang,

  Affiliation Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States of America

  ⨯
• Marlene M. Darfler,

  Affiliation Expression Pathology, Inc., Gaithersburg, Maryland, United States of America

  ⨯
• Michael B. Nicholl,

  Affiliation Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States of America

  ⨯
• Jinsam You,

  Affiliation Monarch LifeSciences LLC, Indianapolis, Indiana, United States of America

  ⨯
• Kerry G. Bemis,

  Affiliation Monarch LifeSciences LLC, Indianapolis, Indiana, United States of America

  ⨯
• Tony J. Tegeler,

  Affiliation Monarch LifeSciences LLC, Indianapolis, Indiana, United States of America

  ⨯
• Mu Wang,

  Affiliation Monarch LifeSciences LLC, Indianapolis, Indiana, United States of America

  ⨯
• Jean-Pierre Wery,

  Affiliation Monarch LifeSciences LLC, Indianapolis, Indiana, United States of America

  ⨯
• Kelly K. Chong,

  Affiliation Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States of America

  ⨯
• Linhda Nguyen,

  Affiliation Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States of America

  ⨯
• Richard A. Scolyer,

  Affiliation Sydney Melanoma Unit, Sydney Cancer Center, Royal Prince Alfred Hospital, Camperdown, Australia

  ⨯
• Dave S. B. Hoon

  * E-mail: hoon@jwci.org

  Affiliation Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States of America

  ⨯